[1] AHMEDIN J,FREDDIE B,MELISSA M,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
[2] 蔡雁,施晓群,金艳.乳腺癌患者术后乳房缺失心理体验的质性研究[J].中华护理杂志,2006,41(2):105-108.
[3] JOSE R,HYE-JUNG H,YOSHINORI K,et al.New advances in breast cancer metastasis[J].Womens Health(Lond Engl),2008,4(6):547-549.
[4] RIBATTI D,ENNAS M G,VACCA A,et al.Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma[J].Eur J Clin Invest,2003,33(5):420-425.
[5] GLIMELIUS I,EDSTRÖM A,FISCHER M,et al.Angiogenesis and mast cells in Hodgkin lymphoma[J].Leukemia,2005,19(12):2360-2362.
[6] STROUCH M J,CHEON E C,SALABAT M R,et al.Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression[J].Clin Cancer Res,2010,16(8):2257-2265.
[7] NONOMURA N,TAKAYAMA H,NISHIMURA K,et al.Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer[J].Br J Cancer,2007,97(7):952-956.
[8] ELPEK G O,GELEN T,AKSOY N H,et al.The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus[J].J Clin Pathol,2001,54(12):940-944.
[9] MOLICA S,VITELLI G,LEVATO D,et al.Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia[J].Eur J Haematol,2003,70(6):373-378.
[10] MOLICA S,VACCA A,CRIVELLATO E,et al.Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia[J].Eur J Haematol,2003,71(2):137-139.
[11] TAN S Y,FAN Y,LUO H S,et al.Prognostic significance of cell infiltrations of immunosuveillance in colorectal cancer[J].World J Gastroenterol,2005,11(8):1210-1214.
[12] 王先松,阮幼冰,武忠弼,等.肥大细胞对肝癌细胞毒性作用的体外实验研究[J].中华肿瘤杂志,1996,18(4):276-278.
[13] DYDUCH G,KACZMARCZYK K,OKON' K.Mast cells and cancer:enemies or allies?[J].Pol J Pathol,2012,63(1):1-7.
[14] OLDFORD S A,HAIDL I D,HOWATT M A,et al.A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth[J].J Immunol,2010,185(11):7067-7076.
[15] MALTBY S,KHAZAIE K,MCNAGNY K M.Mast cells in tumor growth:angiogenesis,tissue remodelling and immune-modulation[J].Biochim Biophys Acta,2009,1796(1):19-26.
[16] AALTOMAA S,LIPPONEN P,PAPINAHO S,et al.Mast cells in breast cancer[J].Anticancer Res,1993,13(3):785-788.
[17] HARTVEIT F,THORESEN S,TANGEN M,et al.Mast cell changes and tumour dissemination in human breast carcinoma[J].Invasion Metastasis,1984,4(3):146-155.
[18] FISHER E R,SASS R,WATKINS G,et al.Tissue mast cells in breast cancer[J].Breast Cancer Res Treat,1985,5(3):285-291.
[19] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2015版)[J].中国癌症杂志,2015,25(9):692-754.
[20] 黄韬,伊丹丹,桑剑锋.肥大细胞在疾病发生发展预后中的作用[J].东南大学学报:医学版,2016,35(3):443-448.
[21] 高小康,孙鹤庆.新辅助化疗对乳腺癌Cerb-B2表达的影响及其临床意义[J].现代医学,2013,41(11):787-791.
[22] ROVERE F D,GRANATA A,MONACO M,et al.Phagocytosis of cancer cells by mast cells in breast cancer[J].Anticancer Res,2009,29(8):3157-3162.
[23] KASHIWASE Y,MORIOKA J,INAMURA H,et al.Quantitative analysis of mast cells in benign and malignant breast lesions.Immunohistochemical study on formalin-fixed,paraffin-embedded tissues[J].Int Arch Allergy Immunol,2004,134(3):199-205.
[24] HILL P B,MARTIN R J.A review of mast cell biology[J].Vet Derm,1998,9(3):145-166.
[25] UESHIMA C,KATAOKA T R,HIRATA M,et al.The killer cell Ig-like Receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion[J].Cancer Immunol Res,2015,3(8):871-880. |